Stephen Lacey is US Editor for International Financing Review, helping to oversee editorial content across the region. He has particular expertise in coverage of the equity capital markets – IPOs, follow-on stock sales, and equity-linked securities – spanning the entire corporate life cycle, from venture and private equity to entry and maturation in the public markets.
- +1 646 223 8808
Biotechs took centre stage in US ECM this past week with seven companies debuting, most in spectacular fashion.
New Frontier, a China-focused special purpose acquisition company, is on its way to IPO success, despite the escalating trade war between the US and China.
Conventional wisdom worldwide is that traditional retailers will be crushed by online competitors.